> The FDA has approved Remicade for ulcerative colitis. Release
> Javelin Pharmaceuticals said that the final results for its Phase II/III study of its painkiller Dyloject hit its primary endpoints. Release
> Esprit Pharma has acquired the outstanding shares of Metagen Pharmaceuticals, gaining control of Prosed EC, a urinary analgesic/ antispasmodic/antiseptic. Story
> Merck KGaA has acquired Spain's Prasfarma for 20 million euros. Report
> Abbott Laboratories has received FDA approval of a new neck stent designed to protect people from strokes. The stent opens narrow arteries in the neck. Article
> Acadia Pharmaceuticals has opened its new R&D facility in Malmo, Sweden. Release
> The FDA has approved an update of Amgen's Neulasta label to include information from a Phase III trial. Report
> Protein Design Labs CFO Glen Sato is resigning at the end of the year. Story
And finally…Three mice infected with bubonic plague bacteria have gone missing from a research center in New Jersey. Story